Filter
421
Filtered Results: 421
Text search:
L.
Newman
Featured
Recommendations
33
New Publications
53
Language
Document type
No document type
164
Studies & Reports
117
Guidelines
71
Manuals
23
Strategic & Response Plan
16
Fact sheets
16
Training Material
10
Infographics
2
Brochures
1
Resource Platforms
1
Countries / Regions
Global
14
Kenya
10
Latin America and the Carribbean
9
India
9
Western and Central Europe
7
Ukraine
6
Asia
6
Russia
6
South Africa
5
Lesotho
4
Burkina Faso
4
Malawi
4
Zimbabwe
4
Eastern Europe
4
Zambia
4
Myanmar / Burma
4
Colombia
3
Chile
3
Senegal
3
Germany
3
South–East Asia Region
3
Eastern Europe and Central Asia
3
Uganda
3
Ghana
2
Rwanda
2
Nigeria
2
Philippines
2
USA
2
Africa
2
Venezuela
2
Bangladesh
2
Ethiopia
2
Ecuador
2
North Macedonia
1
Tajikistan
1
Nepal
1
Benin
1
Cameroon
1
Syria
1
Armenia
1
Tanzania
1
Jordan
1
West and Central Africa
1
Middle East and North Africa
1
Western Pacific Region
1
North America
1
Belgium
1
France
1
Belarus
1
East and Southern Africa
1
Latvia
1
Argentina
1
Lebanon
1
Brazil
1
Namibia
1
Yemen
1
Georgia
1
Mali
1
Botswana
1
South Sudan
1
Liberia
1
Pakistan
1
Guatemala
1
Authors & Publishers
Publication Years
Category
Countries
89
Clinical Guidelines
51
Women & Child Health
21
Public Health
16
Key Resources
14
Capacity Building
12
Pharmacy & Technologies
9
Toolboxes
HIV
52
COVID-19
45
Mental Health
44
AMR
30
Planetary Health
27
TB
17
NTDs
15
Disability
12
Caregiver
12
Social Ethics
11
Refugee
10
Global Health Education
8
Conflict
7
Pharmacy
5
NCDs
5
Natural Hazards
4
Health Financing Toolbox
4
Rapid Response
2
Ebola & Marburg
2
Cholera
1
Zika
1
Results and Lessons Learned from CapacityPlus 2009-2015
Haematologica has published European guidelines for empirical and targeted antibacterial therapy forfebrile neutropenic patients in the era of emerging resistance (ECIL-4). Indeed, collateral damage by broad-spectrum antibiotic therapy includes selection of multidrugresistant pathogens, and incr...
Policy Brief. More languages available here https://apps.who.int/iris/handle/10665/179517
беларускі - Belorussian
TB remains one of the world’s deadliest infectious diseases, second only to COVID-19, and drug-resistant TB strains are still a major concern. In the fight against TB, urgent investment is critical, especially in the context of the ongoing pandemic.
Antimicrobial resistance (AMR) as a serious public health threat was globally acknowledged by WHO in 2015, through the launch of the Global Action Plan (GAP). With a limited number of new antibiotics in the developmental pipeline, many countries are in the process of establishing strategies for anti...
Это учебное пособие содержит информацию о том, как спланировать обучение и содействовать работникам первичного звена медико-санитарной помощи с тем, чтобы они мог...
Front Chem. 2021; 9: 622286.
Published online 2021 Mar 12. doi: 10.3389/fchem.2021.622286
WHO-2019-nCoV-genomic_sequencing
Cardiovascular diseases (CVDs) have collectively remained the leading causes of death worldwide and substantially contribute to loss of health and excess health system costs. The Global Burden of Diseases, Injuries, and Risk Factors (GBD) Study has tracked trends in death and disability since 1990 a...
Nature, biodiversity and health: an overview of interconnections
Urbanization, land use, global trade and industrialization have led to profound and negative impacts on nature, biodiversity and ecosystems across the world. The ongoing depletion of natural resources not only affects environmental c...
The threat climate change poses to health, equity, and development has been rigorously documented. However, in an era marked by economic crisis, regional conflicts, natural disasters and growing disparities between rich and poor, the joint global actions required to address climate change have been ...
The growing understanding of how sequence information can contribute to improved public health is driving global investments in sequencing facilities and programmes. The falling cost and complexity of generating GSD provides opportunities for expanding sequencing capacity; however, challenges to wid...
En el último decenio, los datos de las secuencias genéticas de los patógenos han adquirido un papel crucial en la detección y el manejo de los brotes de enfermedades infecciosas, contribuyendo al desarrollo de pruebas diagnósticas, medicamentos y vacunas y orientando la respuesta sanitaria.
The desired impact of the OH JPA is a world better able to prevent, predict, detect and
respond to health threats and improve the health of humans, animals, plants and the
environment while contributing to sustainable development. The OH JPA aims to work
towards this vision in the following way:
...
Este documento ha sido concebido para proporcionar un marco que respalde los estudios de prevalencia de las ITS en los niveles local y nacional. El propósito de estos estudios es conocer la carga de las infecciones por NG y CT, dos ITS prioritarias que dan lugar a resultados obstétricos y perinata...
WHO's Health in the Green Economy sector briefings examine the health impacts of climate change mitigation strategies considered by the Intergovernmental Panel on Climate Change in their Fourth Assessment Report (Climate Change, 2007). Large, immediate health benefits from some climate change strate...
